Voloridge Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $31.7M | Buy |
|
|||||
|
2023
Q1 | $14.5M | Sell |
|
|||||
|
2022
Q4 | $8.28M | Sell |
|
|||||
|
2022
Q3 | $8.04M | Buy |
|
|||||
|
2022
Q2 | $6.65M | Sell |
|
|||||
|
2022
Q1 | $8.33M | Sell |
|
|||||
|
2021
Q4 | $8.51M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $10M | Buy |
|
|||||
|
2021
Q1 | $1.66M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $416K | Sell |
|
|||||
|
2019
Q4 | $2.97M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $451K | Buy |
|